Skip to content
Stop using now Drug recall · FDA · Published November 19, 2018

Pharm D Solutions Recalls HCG 3000 IU Due to Sterility Risk

Pharm D Solutions recalls Human Chorionic Gonadotropin 3000 IU vials due to lack of sterility assurance. Check lot 10292018:21.

🇺🇸 FDA recall #D-0343-2019DrugPharm D Solutions ›
Take action

Contact the company

Recalling firmPharm D Solutions, LLC1304 S Loop W · Houston, TX 77054-4010
✎ GovInfoNow plain-language explainer

Pharm D Solutions, LLC is recalling Human Chorionic Gonadotropin 3000 IU because its manufacturing processes and equipment were inadequate to ensure the product remained sterile. This recall affects 85 vials distributed in Washington state that were sold with an expiration date of March 31, 2019. The specific lot number involved is 10292018:21. Read more at govinfonow.com/recall/39424-pharm-d-solutions-recalls-hcg-3000-iu-due-to-sterility.

Source Summary by GovInfoNow · govinfonow.com/recall/39424-pharm-d-solutions-recalls-hcg-3000-iu-due-to-sterility · Updated October 11, 2026 · FDA enforcement record: FDA #D-0343-2019

Cite this page

“Pharm D Solutions Recalls HCG 3000 IU Due to Sterility Risk.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39424-pharm-d-solutions-recalls-hcg-3000-iu-due-to-sterility. Based on FDA recall #D-0343-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0343-2019%22&limit=1).

The FDA announced on 2018-11-19 that Pharm D Solutions voluntarily recalled Human Chorionic Gonadotropin 3000 IU due to a lack of sterility assurance, according to the FDA. The recall affects 85 vials distributed in Washington state.

How to tell if you have it

  • Brand: Pharm D Solutions
  • Product: Human Chorionic Gonadotropin 3000 IU
  • NDC: 69699-1738-10
  • Lot: 10292018:21
  • Expiration Date: 3/31/2019

The hazard

The product poses a hazard due to inadequate processes and equipment to assure the sterility of products intended to be sterile, according to the FDA.

Context

GovInfoNow's records show Pharm D Solutions, LLC has 3 other recalls on record since 2016-10-12. Other recent recalls include Pharm D Solutions Recalls Ipamorelin Acetate Vials Due to Lack of Sterility Assurance (2019-05-23) and Pharm D Solutions, LLC recalls Slenderella Compound Injectable (2018-09-10). Similar recent recalls of sterile products include BD ChloraPrep Applicators Sterility Risk (2026-06-11), Apothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk (2026-09-24), and Reliance Bortezomib Injection Recall: Lack of Sterility Risk (2026-06-24).

How to tell if you have this one

Check if you have Human Chorionic Gonadotropin 3000 IU (Rx only) manufactured by Pharm D Solutions. Look for NDC 69699-1738-10 and Lot number 10292018:21 with an expiration date of 3/31/2019.

  • Brand
    Pharm D Solutions
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use the recalled Human Chorionic Gonadotropin 3000 IU vials due to sterility concerns.

  2. Contact the manufacturer

    Call Pharm D Solutions at 1-844-263-6843 for further instructions regarding the recall.

Where it went and when

Where it was distributed

Distributed in Washington.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: yesWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “WA” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Washington.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Nov 19, 201812. FDA classified it Class II: Dec 20, 201823. Published in FDA’s Enforcement Report: Dec 26, 201834. FDA terminated the recall: Oct 13, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0343-2019 (November 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0343-2019 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA